Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.25
-0.43 (-3.11%)
Nov 18, 2024, 1:09 PM EST - Market open
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 21.3, with a low estimate of 15 and a high estimate of 36. The average target predicts an increase of 60.82% from the current stock price of 13.25.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for WVE stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 5 | 5 |
| Buy | 4 | 4 | 3 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +66.10% | Nov 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $17 → $36 | Strong Buy | Maintains | $17 → $36 | +171.80% | Nov 12, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $19 → $22 | Strong Buy | Maintains | $19 → $22 | +66.10% | Nov 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +66.10% | Oct 31, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $15 | Hold | Maintains | $7 → $15 | +13.25% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
70.53M
from 113.31M
Decreased by -37.75%
Revenue Next Year
66.66M
from 70.53M
Decreased by -5.48%
EPS This Year
-1.02
from -0.54
EPS Next Year
-0.99
from -1.02
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 128.1M | 112.7M | 213.2M | ||
| Avg | 70.5M | 66.7M | 97.4M | ||
| Low | 35.1M | 5.9M | 34.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.1% | 59.8% | 219.8% | ||
| Avg | -37.8% | -5.5% | 46.1% | ||
| Low | -69.0% | -91.7% | -48.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.91 | -0.70 | -0.71 | ||
| Avg | -1.02 | -0.99 | -0.96 | ||
| Low | -1.24 | -1.33 | -1.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.